A vector projection approach to predicting HIV protease cleavage sites in proteins
- PMID: 8332607
- DOI: 10.1002/prot.340160206
A vector projection approach to predicting HIV protease cleavage sites in proteins
Abstract
A vector projection method is proposed to predict the cleavability of oligopeptides by extended-specificity site proteases. For an enzyme with eight specificity subsites the substrate octapeptide can be uniquely expressed as a vector in an 8-dimensional space, whose eight bases correspond to the amino acids at the eight subsites, P4, P3, P2, P1, P1', P2', P3', and P4', respectively. The component of such a characteristic vector on each of the eight bases is defined as the frequency of an amino acid occurring at a given site. These frequencies were derived from a set of octapeptides known to be cleaved by HIV protease. The cleavability of an octapeptide can then be estimated from the projection of its characteristic vector on an idealized, optimally cleavable vector. The high ratio of correct prediction vs. total prediction for the data in both the training and the testing sets indicates that the new method is self-consistent and efficient. It provides a rapid and accurate algorithm for analyzing the specificity of any multi-subsite enzyme for which there is no coupling between subsites. In particular, it is useful for predicting the cleavability of an oligopeptide by either HIV-1 or HIV-2 protease, and hence offers a supplementary means for finding effective inhibitors of HIV protease as potential drugs against AIDS.
Similar articles
-
Support Vector Machines for predicting HIV protease cleavage sites in protein.J Comput Chem. 2002 Jan 30;23(2):267-74. doi: 10.1002/jcc.10017. J Comput Chem. 2002. PMID: 11924738
-
Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.Proteins. 1996 Jan;24(1):51-72. doi: 10.1002/(SICI)1097-0134(199601)24:1<51::AID-PROT4>3.0.CO;2-R. Proteins. 1996. PMID: 8628733
-
Prediction of human immunodeficiency virus protease cleavage sites in proteins.Anal Biochem. 1996 Jan 1;233(1):1-14. doi: 10.1006/abio.1996.0001. Anal Biochem. 1996. PMID: 8789141 Review.
-
An alternate-subsite-coupled model for predicting HIV protease cleavage sites in proteins.Protein Eng. 1994 Jan;7(1):65-73. doi: 10.1093/protein/7.1.65. Protein Eng. 1994. PMID: 8140096
-
Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.Biopolymers. 1999;51(1):59-68. doi: 10.1002/(SICI)1097-0282(1999)51:1<59::AID-BIP7>3.0.CO;2-3. Biopolymers. 1999. PMID: 10380353 Review.
Cited by
-
Some illuminating remarks on molecular genetics and genomics as well as drug development.Mol Genet Genomics. 2020 Mar;295(2):261-274. doi: 10.1007/s00438-019-01634-z. Epub 2020 Jan 1. Mol Genet Genomics. 2020. PMID: 31894399 Review.
-
Artificial neural network method for predicting the specificity of GalNAc-transferase.J Protein Chem. 1997 Oct;16(7):689-700. doi: 10.1023/a:1026306520790. J Protein Chem. 1997. PMID: 9330227
-
Artificial neural network method for predicting HIV protease cleavage sites in protein.J Protein Chem. 1998 Oct;17(7):607-15. doi: 10.1007/BF02780962. J Protein Chem. 1998. PMID: 9853675
-
SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis.Comput Biol Chem. 2022 Jun;98:107671. doi: 10.1016/j.compbiolchem.2022.107671. Epub 2022 Mar 28. Comput Biol Chem. 2022. PMID: 35429835 Free PMC article.
-
A sequence-coupled vector-projection model for predicting the specificity of GalNAc-transferase.Protein Sci. 1995 Jul;4(7):1365-83. doi: 10.1002/pro.5560040712. Protein Sci. 1995. PMID: 7670379 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources